Heterotopic ossification in COVID-19: A series of 4 cases

[1]  R. Franco,et al.  SARS-CoV-2 as a Factor to Disbalance the Renin–Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production , 2020, The Journal of Immunology.

[2]  S. Carda,et al.  The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician's view , 2020, Annals of Physical and Rehabilitation Medicine.

[3]  E. Houdayer,et al.  Rehabilitation of COVID-19 patients. , 2020, Journal of rehabilitation medicine.

[4]  B. Altunrende,et al.  Neurogenic heterotopic ossification in Guillain-Barre syndrome: a rare case report , 2020, Journal of musculoskeletal & neuronal interactions.

[5]  J. Lévesque,et al.  Blocking neuromuscular junctions with botulinum toxin A injection enhances neurological heterotopic ossification development after spinal cord injury in mice. , 2019, Annals of physical and rehabilitation medicine.

[6]  P. Denormandie,et al.  Orthopaedic surgery for patients with central nervous system lesions: Concepts and techniques. , 2019, Annals of physical and rehabilitation medicine.

[7]  P. Denormandie,et al.  Resection of neurogenic heterotopic ossification (NHO) of the hip. , 2017, Orthopaedics & traumatology, surgery & research : OTSR.

[8]  P. Denormandie,et al.  Recurrence of heterotopic ossification after removal in patients with traumatic brain injury: A systematic review. , 2016, Annals of physical and rehabilitation medicine.

[9]  D. Hutmacher,et al.  Neurological heterotopic ossification following spinal cord injury is triggered by macrophage‐mediated inflammation in muscle , 2015, The Journal of pathology.

[10]  S. Mehta,et al.  A comparison of heterotopic ossification treatment within the traumatic brain and spinal cord injured population: An evidence based systematic review. , 2011, NeuroRehabilitation.

[11]  N. Blumen,et al.  Heterotopic ossification in Guillain-Barré syndrome: incidence and effects on functional outcome with long-term follow-up. , 2006, Archives of physical medicine and rehabilitation.

[12]  C. Delecourt,et al.  Gene expression in human osteoblastic cells from normal and heterotopic ossification. , 2004, Experimental and molecular pathology.

[13]  M. Haran,et al.  Pharmacological interventions for treating acute heterotopic ossification. , 2004, The Cochrane database of systematic reviews.